Latest 麻豆女优 Health News Stories
Doctors Trying to Prescribe Abortion Pills Across State Lines Stymied by Legislation
Some doctors are getting licensed in multiple states so they can use telemedicine and mail-order pharmacies to provide medication abortions to more women. At the same time, states are cracking down on telemedicine abortions, blunting the efforts of out-of-state doctors.
Pfizer CEO Pushes Yearly Shots for Covid. Not So Fast, Experts Say.
A corporate CEO鈥檚 call for a fourth mRNA shot struck those closely watching the pandemic as self-serving. It creates public pressure for a fourth dose of vaccine before government experts have time to assess the evidence and settle on the best course forward.
KHN鈥檚 鈥榃hat the Health?鈥: Congress Shelves Covid Funding for Now
The Biden administration鈥檚 request for billions more in funding to fight covid-19 hit a snag on Capitol Hill this week, as Democrats objected to Republican demands that money allocated to states but not yet spent be reclaimed. Meanwhile, the big annual spending bill about to cross the finish line addresses other health policy changes, such as giving the FDA authority to regulate 鈥渟ynthetic鈥 nicotine. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Jessie Hellmann of Modern Healthcare join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
KHN鈥檚 鈥榃hat the Health?鈥: It鈥檚 Health Costs, Stupid (2022 Edition)
As the pandemic wanes, for now, the ever-rising cost of health care is again taking center stage. Meanwhile, a year into the Biden administration, the FDA finally has a Senate-confirmed commissioner, Dr. Robert Califf. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet, and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Hannah Wesolowski of the National Alliance on Mental Illness, about how the pandemic has worsened the nation鈥檚 mental health crisis and what can be done about it.
Inside the Tactical Tug of War Over the Controversial Alzheimer鈥檚 Drug
An epic battle is playing out behind the scenes over whether the government should pay for Aduhelm, an FDA-approved Alzheimer鈥檚 drug that scientists say has not been proven to work.
Don鈥檛 Nurse That Moscow Mule 鈥 It Could Be a Health Hazard
Researchers in Montana have found that unsafe levels of copper can leach into the cocktail in less than half an hour.
Cuidado con este c贸ctel, puede ser peligroso para la salud
El Moscow Mule se toma en una jarra de cobre, lo que lo vuelve fascinante, y tal vez peligroso.
KHN鈥檚 鈥榃hat the Health?鈥: FDA Takes Center Stage
Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of 鈥淧DUFA鈥 also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer鈥檚 disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN鈥檚 Julie Rovner to discuss these issues and more.
KHN鈥檚 鈥榃hat the Health?鈥: Paging the HHS Secretary
Health and Human Services Secretary Xavier Becerra is drawing criticism for his hands-off handling of the covid crisis even though the heads of the Centers for Disease Control and Prevention, National Institutes of Health, and FDA report to him. Meanwhile, the Department of Labor looks to enforce mental health 鈥減arity laws鈥 that have failed to achieve their goals. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico, and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN鈥檚 Noam N. Levey, who reported and wrote the latest KHN-NPR 鈥淏ill of the Month鈥 episode about a large emergency room bill for a small amount of medical care.
KHN鈥檚 鈥榃hat the Health?鈥: Dealing With Drug Prices
Medicare officials tentatively plan to restrict the use of a controversial Alzheimer鈥檚 drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more.
鈥楢n Arm and a Leg鈥: The Rapid-Test Edition: Who’s Making a Buck?
In this episode, host Dan Weissmann talks to reporters who investigated the shortage of tests and traced the U.S. rapid-testing problem back to government agencies.
The Vaccine Rollout Was a Success. But Events Within and Beyond Biden鈥檚 Control Stymied Progress.
There were variants, vaccine hesitancy and messaging mix-ups. And, despite campaign promises, Biden and his administration sometimes took actions or made statements without waiting for full scientific evidence to back them up.
KHN鈥檚 鈥榃hat the Health?鈥: Oh, Oh, Omicron
Even before the omicron variant of covid starts to spread widely in the U.S., hospitals are filling up with post-holiday delta cases. Meanwhile, the Supreme Court signals 鈥 loudly 鈥 that 2022 will be the year it rolls back abortion rights in a big way. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Ellen McIntire of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more.
Con m谩s muertes por sobredosis, defensores claman por una naloxona de venta libre
La administraci贸n Biden ha destinado $30 millones a programas de reducci贸n de da帽os por adicciones. Pero defensores dicen que la principal barrera es que la naloxona sigue siendo de venta bajo receta.
With Overdose Deaths Surging, Advocates on the Ground Push for Over-the-Counter Naloxone
Harm-reduction groups say that requiring a doctor to sign off on their orders of the overdose reversal drug is one of the biggest barriers they face in obtaining the lifesaving medication.
驴Ha llegado el momento de cambiar la definici贸n de “totalmente vacunado”?
Cient铆ficos y funcionarios de salud p煤blica debaten cu谩ndo ser谩 el momento de cambiar la definici贸n de “totalmente vacunado” para que incluya una vacuna de refuerzo.
Is It Time to Change the Definition of 鈥楩ully Vaccinated鈥?
Experts weigh in as the federal government urges everyone to get boosted amid concerns over omicron, a new covid variant.
Hospitals Refused to Give Patients Ivermectin. Lockdowns and Political Pressure Followed.
Hospitals in Montana and Idaho reported threats and harassment from public officials and family members of patients who were denied treatment with a drug not authorized to treat covid-19.
KHN鈥檚 鈥榃hat the Health?鈥: The Big Biden Budget Bill Passes the House
President Joe Biden鈥檚 social spending budget is on its way to the U.S. Senate, where Democratic leaders are (optimistically) hoping to complete work by the end of the year. Meanwhile, covid is surging again in parts of the country, along with the political divides it continues to cause. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins School of Public Health, and Mary Agnes Carey of KHN join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner previews next week鈥檚 Supreme Court abortion oral arguments with Florida State University law professor Mary Ziegler.
Why You Can鈥檛 Find Cheap At-Home Covid Tests
You probably won鈥檛 be testing everyone at your Thanksgiving table for covid because the tests are expensive and hard to find. Why? The federal government is partly to blame.
